NetworkNewsAudio

TuesdayNov 02, 2021 8:30 am

NetworkNewsAudio – Valour Inc., a Subsidiary of DeFi Technologies Inc. (NEO: DEFI) (GR: RMJ.F) (OTC: DEFTF), Launches World’s First Uniswap Exchange Traded Product

DeFi Technologies (NEO: DEFI) (GR: RMJ.F) (OTC: DEFTF), a technology company bridging the gap between traditional capital markets and decentralized finance, today announces that its subsidiary Valour Inc. ("Valour"), an issuer of digital asset exchange traded products ("ETPs"), will launch Valour Uniswap (VALOUR UNISWAP - CH1114178846) on the Börse Frankfurt Zertifikate AG ("Frankfurt"). The Valour Uniswap ETP enables investors to gain exposure to UNI, the native token of the world's largest decentralised exchange, Uniswap, simply and securely, via their bank or broker. To view the full press release, visit https://nnw.fm/xQp5l About DeFi Technologies Inc. DeFi Technologies is a digital asset investment firm bridging the…

Continue Reading

FridayOct 22, 2021 7:55 am

NetworkNewsAudio – Valour Inc., DeFi Technologies Inc.’s (NEO: DEFI) (GR: RMJ.F) (OTC: DEFTF) Wholly Owned Subsidiary, Reaches Record US$250m in Assets Under Management

Related Press Release More than a US$40m asset increase since beginning of September DeFi Technologies (NEO: DEFI) (GR: RMJ.F) (OTC: DEFTF), a technology company bridging the gap between traditional capital markets and decentralized finance, announced today that its wholly owned subsidiary, Valour Inc. ("Valour"), the pioneering issuer of digital asset exchange traded products ("ETPs"), has surpassed US$250 million (equivalent of 2.1 billion Swedish Krona ("SEK")) in assets under management ("AUM"). This achievement marks an exceptional first ten months of 2021, as AUM increased more than 2560% since the beginning of the year. In the last 30 days, AUM has increased more than US$40m . To…

Continue Reading

FridayOct 15, 2021 8:30 am

NetworkNewsAudio – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Capturing Consumer Attention in Booming Market

Related Editorial As recently as 2015, the retail sales for alkaline waters, those with a pH between 7.0 and 10.0, were less than $95 million. With consumers taking a more proactive approach towards health, alkaline sales are booming. Industry authority Beverage Marketing Corp. forecasts retail sales in the category to balloon to $1.3 billion by 2023, representing 20% of the entire value-added water category. Drivers abound to support the 42.6% compound annual growth rate for the forecast period, which are undergirding exponential growth for The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) (Profile), the largest independent alkaline water company in…

Continue Reading

ThursdayOct 14, 2021 8:30 am

NetworkNewsAudio – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Harnessing Power of Real-World Data

Related Editorial Today it seems almost unimaginable to wait days or weeks for results from a blood test, but that was the case only a few decades ago. Automated equipment, portable devices and medical innovation have underscored a healthcare evolution that allows for faster diagnoses and subsequent treatment to improve patient outcomes. Innovation remains at the heart of healthcare, keeping up with the times as doctors, patients and insurance companies now expect near-instant results that detect disease at earlier and earlier stages, sometimes even before symptoms present. Early detection and screening have been proven to save lives and billions of…

Continue Reading

MondayOct 11, 2021 8:00 am

NetworkNewsAudio – DeFi Technologies (NEO: DEFI) (OTC: DEFTF) Expands Executive Management Team as it Focuses on Growth in European and Global Markets along with New Product Launches

Related Press Release DeFi Technologies Inc. (NEO: DEFI) (GR: RMJ.F) (OTC: DEFTF), a digital asset investment firm bridging the gap between traditional capital markets and decentralized finance, recently announced the expansion of its management team. Wouter Witvoet, President of DeFi Technologies, stated, “By expanding the management team with Johan and Diana, we have two seasoned professionals who will help grow our footprint in Europe in our asset management business and globally in DeFi Governance and Ventures. I am also thrilled that Russell Starr has agreed to come on board as CEO. Russell is an experienced capital markets professional who can…

Continue Reading

MondayOct 11, 2021 8:00 am

NetworkNewsAudio – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Doses First Group of Patients with Berubicin, an FDA-Designated Fast Track Drug Candidate, in the Potentially Pivotal Study

Related Press Release CNS Pharmaceuticals (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, recently announced the dosing of the first patients in its Berubicin clinical development program for the treatment of recurrent glioblastoma multiforme (GBM), one of the most aggressive types of brain cancer. Further patient enrollment, randomization and dosing is currently underway as well as a robust lineup of clinical sites located globally which are advancing toward activation and enrollment. To view the original press release, visit https://nnw.fm/QlM2S About…

Continue Reading

MondayOct 04, 2021 8:30 am

NetworkNewsAudio – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Sees Stellar Growth in Fast-Growing Beverage Space

Related Editorial As consumers continue to insist on more healthy options in choices in their lives, the global health drinks market is projected to see consistent, continued growth, with a CAGR of 7.88% during the next five years. That growth will come from all sectors, including convenience store sales, e-commerce orders and the hospitality sector, which is recovering from COVID-19 slowdowns. Bottled water continues to be America’s favorite drink, outselling soda for the first time in 2016 and continuing that feat every year since. Leading the healthy beverage charge are companies, such as The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE:…

Continue Reading

FridayOct 01, 2021 8:30 am

NetworkNewsAudio – Flora Growth Corp. (NASDAQ: FLGC) Has Cannabis Edge in Colombia

Related Editorial When Democrats took control of Capitol Hill during the elections in November 2020, there was growing optimism that federal legalization of cannabis was in the cards for Americans. Nine months into the new administration, progress has been slow in the United States. Latin American (“LATAM”) countries, on the other hand, have moved forward with new laws ending cannabis prohibition and supporting the industry, moves to generate government revenue, cut into illicit sales and bring novel therapeutic options to people in need. Colombia, Mexico and Panama are emerging as global pioneers promoting responsible cannabis commerce, which bodes well for…

Continue Reading

FridayOct 01, 2021 8:30 am

NetworkNewsAudio – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Takes Lead as Cannabis Market Matures

Related Editorial As part of the reopening economy, investors should be monitoring several trends in the healthcare space, including several that fall in the “natural wellness” or “natural alternatives'' categories.  The COVID-19 pandemic shone a bright light on lifestyle and self-care as people were encouraged, and often mandated, to stay at home. The trend further points to the next phase of cannabis market maturation, dubbed cannabis 3.0, against the backdrop of legislators discussing the Cannabis Administration and Opportunity Act that would create a national market for marijuana. Looking to address this opportunity, BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) (Profile)…

Continue Reading

ThursdaySep 30, 2021 8:30 am

NetworkNewsAudio – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Bringing Therapeutic Options to Diseases with Unmet Needs

Related Editorial The emergence of psychedelic therapies as a popular investment a few years ago was mostly underscored by investors that rode the cannabis wave seeing a brand-new opportunity with drugs such as psilocybin, LSD, MDMA, DMT, and others to address hard-to-treat mental health diseases, namely depression, addiction, post-traumatic stress disorder and anxiety. As strides are being made on those fronts, a second investment wave is swelling on the horizon that looks to feature expanded indications and bring new therapeutic options to diseases with unmet needs. Psychedelics could redefine standards of care for chronic diseases and reshape psychiatry, including counseling…

Continue Reading